| SpectraBase Spectrum ID |
JIHM7S3FEqu |
| Name |
4-(2-[7-Methylindol-3-yl]ethyl)morpholine |
| Classification |
Tryptamine designer drug analog |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
244.157563271 u |
| Formula |
C15H20N2O |
| InChI |
InChI=1S/C15H20N2O/c1-12-3-2-4-14-13(11-16-15(12)14)5-6-17-7-9-18-10-8-17/h2-4,11,16H,5-10H2,1H3 |
| InChIKey |
OPDAWUFOXFKYPH-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
244.338 g/mol |
| Nominal Mass |
244 u |
| Quality |
987 |
| Retention Index |
2243 |
| SMILES |
C=12C(NC=C2CCN2CCOCC2)=C(C=CC1)C |
| SPLASH |
splash10-0udi-2900000000-51caaaf37453a80c5dc6 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Indole,7-methyl-3-(2-morpholin-4-yl-ethyl)1H-
7-Methyl-3-(2-morpholin-4-yl-ethyl)1H-indole |
| Technique |
GC/MS |
| Wiley ID |
DD2024_016283 |
![4-(2-[7-Methylindol-3-yl]ethyl)morpholine](/api/spectrum/JIHM7S3FEqu/structure.png?h=300&w=458 "4-(2-[7-Methylindol-3-yl]ethyl)morpholine")
